We describe two dark-skinned patients who developed hyperpigmented skin and tongue lesions during combination therapy with IFN and ribavirin.
tongue lesions
IFN
hyperpigmented skin
ribavirin
hyperpigmented skin
IFN
tongue lesions
ribavirin